Rutgers University Study of the Genetics of Kidney Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey

About this trial

The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age 18 years or older

currently living in the United States

able to understand and follow written instructions in English

have access to the internet and a computer, laptop, tablet or smart phone

Disqualifiers

Not able to meet or fulfill any of the inclusion criter

Trial population

The study population consists of anyone at least 18 years old who lives in the United States, including both individuals who have or had kidney disease and those who have not. Participants include males, females, non-binary, and all race-ethnic groups.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • Saliva sample

    Genetic

    Saliva sample is sent via prepaid US Mail for DNA extraction

  • Health surveys

    Other intervention

    Health surveys are filled out online in the study portal.

Treatment groups

50,000 Participants
are divided into 2 treatment groups
Group A: Kidney disease cases2 interventions
Group B: Kidney disease controls2 interventions

Trial outcomes

Primary outcomes

1

Genetic risk variants associated with kidney disease

Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with kidney disease and/or kidney disease subtype.

Time frame
2 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rutgers, The State University of New Jersey

Lead sponsor

Regeneron Pharmaceuticals

Collaborator